GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Silco Pharmaceuticals Ltd (DHA:SILCOPHL) » Definitions » 3-Year Revenue Growth Rate

Silco Pharmaceuticals (DHA:SILCOPHL) 3-Year Revenue Growth Rate : 0.00% (As of . 20)


View and export this data going back to 2019. Start your Free Trial

What is Silco Pharmaceuticals 3-Year Revenue Growth Rate?

Silco Pharmaceuticals's Revenue per Share for the six months ended in . 20 was BDT0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Competitive Comparison of Silco Pharmaceuticals's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Silco Pharmaceuticals's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Silco Pharmaceuticals's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Silco Pharmaceuticals's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Silco Pharmaceuticals's 3-Year Revenue Growth Rate falls into.



Silco Pharmaceuticals 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Silco Pharmaceuticals  (DHA:SILCOPHL) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Silco Pharmaceuticals 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Silco Pharmaceuticals's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Silco Pharmaceuticals (DHA:SILCOPHL) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
41, Nurani, Bankolapara, Subidbazar, Sylhet, BGD, 3100
Silco Pharmaceuticals Ltd is engaged in manufacturing and marketing of pharmaceuticals finished products in the categories of Antibiotics, Analgesics, Anti diabetics, Narcotics, Antipyratics, Anti-inflammatory Drugs, Antiulcerants, Multi medicines which are sold mainly in local market.

Silco Pharmaceuticals (DHA:SILCOPHL) Headlines

No Headlines